Giovanni Magni
CIK 1292816 · View on SEC EDGAR ↗
First SEC filing: June 4, 2004 · Latest: June 4, 2004
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 19, 2020 | BIO | S | 315 | $517.64 | $163,057 | 33,270 Direct | -0.94% | Disposed | -27.8% (price as of 2026-08-21) |
| Aug. 19, 2020 | BIO | S | 5,392 | $518.76 | $2,797,154 | 27,878 Direct | -16.21% | Disposed | -27.9% (price as of 2026-08-21) |
| Aug. 19, 2020 | BIO | S | 1,133 | $519.89 | $589,035 | 26,745 Direct | -4.06% | Disposed | -28.1% (price as of 2026-08-21) |
| Aug. 19, 2020 | BIO | S | 5,668 | $520.94 | $2,952,688 | 21,077 Direct | -21.19% | Disposed | -28.2% (price as of 2026-08-21) |
| Aug. 19, 2020 | BIO | S | 339 | $521.86 | $176,911 | 20,738 Direct | -1.61% | Disposed | -28.4% (price as of 2026-08-21) |
| Aug. 18, 2020 | BIO | S | 2,382 | $518.81 | $1,235,805 | 12,435 Direct | -16.08% | Disposed | -27.9% (price as of 2026-08-21) |
| May 18, 2017 | BIO | S | 2,113 | $220.23 | $465,346 | 10,543 Direct | -16.70% | Disposed | 69.7% (price as of 2026-08-21) |
| Sept. 12, 2016 | BIO | S | 438 | $155.02 | $67,899 | 13,357 Direct | -3.18% | Disposed | 141.1% (price as of 2026-08-21) |
| Dec. 12, 2014 | BIO | S | 5,000 | $117.38 | $586,900 | 11,811 Direct | -29.74% | Disposed | 218.5% (price as of 2026-08-21) |
| Dec. 6, 2012 | BIO | S | 5,404 | $103.85 | $561,205 | 8,189 Direct | -39.76% | Disposed | 259.9% (price as of 2026-08-21) |
| Dec. 6, 2012 | BIO | S | 201 | $104.76 | $21,057 | 7,988 Direct | -2.45% | Disposed | 256.8% (price as of 2026-08-21) |
| Sept. 10, 2012 | BIO | S | 92 | $103.49 | $9,521 | 7,748 Direct | -1.17% | Disposed | 261.2% (price as of 2026-08-21) |
| June 12, 2012 | BIO | S | 87 | $96.51 | $8,396 | 7,600 Direct | -1.13% | Disposed | 287.3% (price as of 2026-08-21) |
| June 11, 2012 | BIO | S | 89 | $96.49 | $8,588 | 7,687 Direct | -1.14% | Disposed | 287.4% (price as of 2026-08-21) |
| Sept. 9, 2011 | BIO | S | 90 | $94.85 | $8,536 | 7,536 Direct | -1.18% | Disposed | 294.1% (price as of 2026-08-21) |
| June 14, 2011 | BIO | S | 87 | $117.53 | $10,225 | 7,386 Direct | -1.16% | Disposed | 218.1% (price as of 2026-08-21) |
| June 13, 2011 | BIO | S | 89 | $117.30 | $10,440 | 7,473 Direct | -1.18% | Disposed | 218.7% (price as of 2026-08-21) |
| March 7, 2011 | BIO | S | 100 | $115.27 | $11,527 | 13,596 Direct | -0.73% | Disposed | 224.3% (price as of 2026-08-21) |
| March 7, 2011 | BIO | S | 6,274 | $115.00 | $721,510 | 7,322 Direct | -46.15% | Disposed | 225.0% (price as of 2026-08-21) |
Showing latest 100 of 130 transactions
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Sept. 3, 2020 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (371) | — | — | 371 | Disposed |
| Aug. 19, 2020 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (3,500) | $84.57 | Sept. 8, 2020 | 3,500 | Disposed |
| Aug. 19, 2020 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (3,500) | $98.04 | Nov. 4, 2021 | 3,500 | Disposed |
| Aug. 19, 2020 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (3,250) | $107.32 | Sept. 12, 2022 | 3,250 | Disposed |
| Aug. 19, 2020 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (3,200) | $117.00 | Sept. 11, 2023 | 3,200 | Disposed |
| Aug. 19, 2020 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (3,000) | $119.54 | Sept. 10, 2024 | 3,000 | Disposed |
| Aug. 19, 2020 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (2,000) | $139.56 | Sept. 11, 2025 | 2,000 | Disposed |
| Aug. 19, 2020 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (1,200) | $160.37 | Sept. 8, 2026 | 1,200 | Disposed |
| Aug. 19, 2020 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (1,000) | $215.98 | Sept. 5, 2027 | 1,000 | Disposed |
| Aug. 19, 2020 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (500) | $326.15 | Sept. 4, 2028 | 500 | Disposed |
| May 11, 2018 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (3,500) | $88.00 | June 11, 2018 | 3,500 | Disposed |
| Sept. 11, 2016 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (240) | — | — | 240 | Disposed |
| Sept. 11, 2016 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (500) | — | — | 500 | Disposed |
| Sept. 10, 2016 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (400) | — | — | 400 | Disposed |
| Sept. 8, 2016 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (2,000) | — | — | 2,000 | Acquired |
| Sept. 8, 2016 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (2,000) | $160.37 | Sept. 8, 2026 | 2,000 | Acquired |
| Dec. 12, 2014 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (5,000) | $57.49 | Feb. 9, 2015 | 5,000 | Disposed |
| Nov. 4, 2014 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (240) | — | — | 240 | Disposed |
| Sept. 12, 2014 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (240) | — | — | 240 | Disposed |
| Sept. 11, 2014 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (240) | — | — | 240 | Disposed |
| Sept. 10, 2014 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (2,000) | — | — | 2,000 | Acquired |
| Sept. 10, 2014 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (3,000) | $119.54 | Sept. 10, 2024 | 3,000 | Acquired |
| Sept. 8, 2014 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (240) | — | — | 240 | Disposed |
| June 10, 2014 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (240) | — | — | 240 | Disposed |
| Nov. 15, 2013 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (6,000) | $53.75 | Feb. 4, 2014 | 6,000 | Disposed |
| Nov. 4, 2013 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (240) | — | — | 240 | Disposed |
| Sept. 12, 2013 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (240) | — | — | 240 | Disposed |
| Sept. 11, 2013 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (1,200) | — | — | 1,200 | Acquired |
| Sept. 11, 2013 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (3,200) | $117.00 | Sept. 11, 2023 | 3,200 | Acquired |
| Sept. 8, 2013 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (240) | — | — | 240 | Disposed |
| June 10, 2013 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (240) | — | — | 240 | Disposed |
| Dec. 6, 2012 | BIO | Incentive Stock Option (right to buy) | Bio-Rad A Common Stock (4,885) | $35.50 | Feb. 5, 2013 | 4,885 | Disposed |
| Dec. 6, 2012 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (720) | $35.50 | Feb. 5, 2013 | 720 | Disposed |
| Nov. 4, 2012 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (240) | — | — | 240 | Disposed |
| Sept. 12, 2012 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (1,200) | — | — | 1,200 | Acquired |
| Sept. 12, 2012 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (3,250) | $107.32 | Sept. 12, 2022 | 3,250 | Acquired |
| Sept. 8, 2012 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (240) | — | — | 240 | Disposed |
| June 10, 2012 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (240) | — | — | 240 | Disposed |
| Nov. 4, 2011 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (1,200) | — | — | 1,200 | Acquired |
| Nov. 4, 2011 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (3,500) | $98.04 | Nov. 4, 2021 | 3,500 | Acquired |
| Sept. 8, 2011 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (240) | — | — | 240 | Disposed |
| June 10, 2011 | BIO | Restricted Stock Units | Bio-Rad A Common (240) | — | — | 240 | Disposed |
| March 7, 2011 | BIO | Incentive Stock Option (right to buy) | Bio-Rad A Common Stock (6,374) | $28.61 | Feb. 6, 2012 | 6,374 | Disposed |
| March 4, 2011 | BIO | Incentive Stock Option (right to buy) | Bio-Rad A Common Stock (626) | $28.61 | Feb. 6, 2012 | 626 | Disposed |
| Sept. 13, 2010 | BIO | Incentive Stock Option (right to buy) | Bio-Rad A Common Stock (6,500) | $10.75 | Sept. 19, 2010 | 6,500 | Disposed |
| Sept. 8, 2010 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (1,200) | — | — | 1,200 | Acquired |
| Sept. 8, 2010 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (3,500) | $84.57 | Sept. 8, 2020 | 3,500 | Acquired |
| June 10, 2010 | BIO | Restricted Stock Units | Bio-Rad A Common (240) | — | — | 240 | Disposed |
| Jan. 19, 2010 | BIO | Incentive Stock Option (right to buy) | Bio-Rad A Common Stock (1,000) | $11.94 | Feb. 2, 2010 | 1,000 | Disposed |
| June 10, 2009 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (1,200) | — | — | 1,200 | Acquired |
| June 10, 2009 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (3,500) | $74.27 | June 10, 2019 | 3,500 | Acquired |
| June 11, 2008 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (3,500) | $88.00 | June 11, 2018 | 3,500 | Acquired |
| Aug. 1, 2007 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (3,500) | $75.32 | Aug. 1, 2017 | 3,500 | Acquired |
| April 3, 2006 | BIO | Incentive Stock Option (right to buy) | Bio-Rad A Common Stock (1,880) | $62.47 | April 3, 2016 | 1,880 | Acquired |
| April 3, 2006 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (4,120) | $62.47 | April 3, 2016 | 4,120 | Acquired |
| Feb. 9, 2005 | BIO | Incentive Stock Option (right to buy) | Bio-Rad A Common Stock (1,000) | $57.49 | Feb. 9, 2015 | 1,000 | Acquired |
| Feb. 9, 2005 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (4,000) | $57.49 | Feb. 9, 2015 | 4,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 8 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| June 4, 2004 | BIO | Incentive Stock Option→ Class A Common Stock (7,000) | 7,000 | Direct |
| June 4, 2004 | BIO | Incentive Stock Option→ Class A Common Stock (4,885) | 4,885 | Direct |
| June 4, 2004 | BIO | Non Qualified Stock Option→ Class A Common Stock (720) | 720 | Direct |
| June 4, 2004 | BIO | Incentive Stock Option→ Class A Common Stock (4,102) | 4,102 | Direct |
| June 4, 2004 | BIO | Non Qualified Stock Option→ Class A Common Stock (1,898) | 1,898 | Direct |
| June 4, 2004 | BIO | Incentive Stock Option→ Class A Common Stock (1,500) | 1,500 | Direct |
| June 4, 2004 | BIO | Incentive Stock Option→ Class A Common Stock (5,000) | 5,000 | Direct |
| June 4, 2004 | BIO | Incentive Stock Option→ Class A Common Stock (1,000) | 1,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2014 | $425,715 | — | — | — | — | — | — | $1,026,400 |
| 2013 | $406,665 | — | — | — | $61,635 | — | $16,854 | $745,868 |
| 2012 | $392,769 | — | — | — | $172,082 | — | $14,282 | $815,559 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.